Anticipated to Price IPO Tonight.
Novus Capital Corp. (NOVSU), filed an amended S-1 this morning, further revising the terms of their IPO. In Novus Capital’s initial filing, this was a 1/2 warrant, 24 months deal. Subsequent to that, those terms were revised to 21 months and 3/4 of a warrant. As of this morning, NOVSU is now 18 months with a full warrant included in it’s unit.
To add additional fuel to the terms fire, GigCapital3 (GIK.U) debuted today and even though Gig3 IPO’d with $10.10 in trust, 3/4 of a warrant and 18 months, it still opened at $9.90. This is in stark contrast to Jaws Acquisition Corp (JWS.U), which also debuted today, and is currently trading at $10.15.
It begs the question…do investors only want to buy the tier-1, brand name IPOs? Social Capital II is currently trading at $10.52, Social Capital III, at $10.39. CC Neuberger, at $10.14, and Jaws at $10.15. These are all high-profile SPACs, led by well known names, and as you can see below, these are the only SPACs to be trading significantly above $10.00 (of the SPACs that have IPO’d since the Covid-19 crisis). Furthermore, Jaws did not need to revise its terms at all.
It’s a big signal when Gig3 overfunds its trust at $10.10 and it still can’t trade above issue price at IPO. And that’s a big problem for the rest of the sub-elite SPACs looking to IPO going forward because now it’s going to be even more challenging to get enough indications to cover a book.
So as was previously theorized, there appears to be a Darwinian “Survival of the Fittest” happening where only the elite deals are able to IPO. That’s not to say we’re totally there yet, but there’s going to be a lot riding on Novus Capital’s day-one performance tomorrow. If Novus breaks issue price too, it will get increasingly harder for the rest of the field to get the indications they need when investors can just buy in the secondary market below $10.00.
Let’s see what happens.
Revised summary of terms below:
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...